Related references
Note: Only part of the references are listed.Effect of omadacycline alone and in combination with meropenem against carbapenem-resistant Acinetobacter baumannii isolates
J. Nicholas O'Donnell et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii
Yun Li et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
Taylor Abbey et al.
MICROBIOLOGY SPECTRUM (2022)
Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals
Alejandro Iregui et al.
MICROBIAL DRUG RESISTANCE (2021)
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Ioannis Kyriakidis et al.
PATHOGENS (2021)
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
Jeongwoo Jo et al.
MICROBIOLOGY SPECTRUM (2021)
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf
Xiaoting Hua et al.
EMERGING MICROBES & INFECTIONS (2021)
Evaluation of Tigecycline and Minocycline Susceptibility among Clinical Isolates of Carbapenem Resistant Acinetobacter Species
Asna Parveen et al.
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS (2021)
In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
Ian Morrissey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Early Experience With Eravacycline for Complicated Infections
Sara Alosaimy et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Emerging High-Level Tigecycline Resistance: Novel Tetracycline Destructases Spread via the Mobile Tet(X)
Liang-Xing Fang et al.
BIOESSAYS (2020)
Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC
Yue Shi et al.
INFECTION GENETICS AND EVOLUTION (2020)
Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes ofPseudomonas aeruginosaandAcinetobacter baumanniiisolated in clinical samples from Northeast of Iran
Bahman Mirzaei et al.
BMC RESEARCH NOTES (2020)
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations
Richard R. Watkins et al.
CLINICAL INFECTIOUS DISEASES (2019)
Eravacycline: The Tetracyclines Strike Back
Maria Heaney et al.
ANNALS OF PHARMACOTHERAPY (2019)
In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates
H. Selcuk Ozger et al.
JOURNAL OF ANTIBIOTICS (2019)
In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China
Chunjiang Zhao et al.
BMC INFECTIOUS DISEASES (2019)
Eravacycline, a newly approved fluorocycline
Young Ran Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
World Health Organization Report: Current Crisis of Antibiotic Resistance
Amin Talebi Bezmin Abadi et al.
BIONANOSCIENCE (2019)
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
Harald Seifert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study
Marya D. Zilberberg et al.
JOURNAL OF HOSPITAL MEDICINE (2016)
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
S. Ken Tanaka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections
Stephen Villano et al.
FUTURE MICROBIOLOGY (2016)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014
Lindsey M. Weiner et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)
Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients
Constantinos Tsioutis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Organocatalyzed Mannich Reactions on Minocycline: Towards Novel Tetracycline Antibiotics
Tirivashe E. Chiwunze et al.
SOUTH AFRICAN JOURNAL OF CHEMISTRY-SUID-AFRIKAANSE TYDSKRIF VIR CHEMIE (2016)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
Marie Abdallah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Adverse Reactions Associated with Systemic Polymyxin Therapy
Julie Ann Justo et al.
PHARMACOTHERAPY (2015)
Sigma S-Dependent Antioxidant Defense Protects Stationary-Phase Escherichia coli against the Bactericidal Antibiotic Gentamicin
Jing-Hung Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Genomic Analysis Reveals Distinct Concentration-Dependent Evolutionary Trajectories for Antibiotic Resistance in Escherichia coli
Aalap Mogre et al.
DNA RESEARCH (2014)
Gram-Negative Infections in Adult Intensive Care Units of Latin America and the Caribbean
Carlos M. Luna et al.
CRITICAL CARE RESEARCH AND PRACTICE (2014)
High endemic levels of multidrug-resistant Acinetobacter baumannii among hospitals in southern Brazil
Andreza F. Martins et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Benjamin A. Evans et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Acinetobacter baumannii An emerging opportunistic pathogen
Aoife Howard et al.
VIRULENCE (2012)
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Doo Ryeon Chung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: Antimicrobial and organizational strategies
Guglielmo Consales et al.
JOURNAL OF CRITICAL CARE (2011)
Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections
Joon Young Song et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Building a benchmark through active surveillance of intensive care unit-acquired infections: the Italian network SPIN-UTI
A. Agodi et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Multidrug Resistant Acinetobacter
Vikas Manchanda et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Shiri Navon-Venezia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
Ronald N. Jones et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides
Farid El'Garch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Tigecycline: First of a new class of antimicrobial agents
Warren E. Rose et al.
PHARMACOTHERAPY (2006)
Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis
G Orhan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Determination of minimum inhibitory concentrations
JM Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent
SJ Projan
PHARMACOTHERAPY (2000)
Share Paper
